OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out LLY/  DE000GG1MM99  /

EUWAX
6/25/2024  11:23:55 AM Chg.+0.18 Bid3:14:51 PM Ask3:14:51 PM Underlying Strike price Expiration date Option type
27.32EUR +0.66% 27.72
Bid Size: 2,000		 27.79
Ask Size: 2,000		 Eli Lilly and Co 601.2483 USD 12/31/2078 Call
GlobeNewswire 6/21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 6/17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 6/17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 6/14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 6/10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 6/10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 6/6 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 6/5 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 6/3 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 5/30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 5/24 Eli Lilly to reveal $5.3B production boost
TeleTrader 5/21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 5/16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 5/16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 5/13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 5/9 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 5/8 Erasca Reports First Quarter 2024 Business Updates and Financial Results
GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 5/1 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors